In recent months, headlines on both sides of the Atlantic have told the same story. U.S. hospitals are cutting back surgical schedules because they simply don’t have enough staff, while NHS figures show more than seven million people still waiting for treatment in England. A regrettably high number of procedures are cancelled on the day ... Read More

Oncology saw progress fortnight: sevabertinib earned dual Breakthrough Therapy tags for first-line HER2-mutant NSCLC, Atossa received a Study May Proceed letter for oral Z-endoxifen in ER-positive, HER2-negative metastatic breast cancer, and Curadel’s CPI-008 gained US and EU orphan status for pancreatic cancer imaging. Pfizer’s BREAKWATER reported 64 percent ORR for Braftovi plus cetuximab plus FOLFIRI versus 39 percent for standard therapy in BRAF V600E mCRC. Summit filed an ivonescimab BLA, Eureka’s ECT204 secured RMAT, Merck’s pimicotinib NDA advanced, and Tahoe–Alloy launched an AI-ADC joint venture.

Asus has reiterated that it will “no longer” be making “new” Android smartphones with its focus shifting towards the market built up by AI. more…

AGC Biologics Celebrates U.S. and EU Approval of Fondazione Telethon’s Waskyra™ Treatment for Wiskott-Aldrich Syndrome  BioSpace

VENLO, Netherlands–(BUSINESS WIRE)–QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the fourth quarter of 2025. Press release date / time: Wednesday, February 4 shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time. Conference call date / time: Thursday, February 5, at 15:30 Frankfurt …

A 2025 oncology review, covering trial readouts, regulatory activity, safety and delivery innovations, diagnostics, and 2026 catalysts.

The Blood Transfusion service at Aneurin Bevan University Health Board (ABUHB) has gone live with Clinisys WinPath.

In this week’s Oncology update regulatory milestones and late-stage clinical updates dominated, including expedited pathways, pivotal trial readouts, and filings […] The post Oncology Video Recap—January 19, 2026 appeared first on LucidQuest Ventures.

Makary cites higher FDA user fees as one key to counter China biotech  Endpoints News

Ofek Kesef Asset Management has released its 2026 strategic investment outlook, outlining a shift in portfolio positioning as global monetary policy paths diverge and liquidity conditions tighten following the post-2025 expansion cycle. According to the firm, the outlook reflects changes in the macroeconomic environment, including diverging central bank policies among major economies and increasing volatility …

This Public Health video recap highlights major population health and preventive care developments, spanning cancer outcomes, mental health, aging, infectious […] The post Public Health Video Recap—January 16, 2025 appeared first on LucidQuest Ventures.

This week’s Hematology update spans regulatory milestones, late-stage clinical readouts, and early-phase progress across hematologic cancers and bleeding disorders. Themes […] The post Hematology Today—January 19, 2026 appeared first on LucidQuest Ventures.

This week’s Oncology roundup covers regulatory approvals and filings, late-stage trial starts, special designations, and market availability across oncology, spanning […] The post Oncology Today—January 19, 2026 appeared first on LucidQuest Ventures.

Multiple alarms, RPE workout scoring and map enhancements are just some of the updates landing with Polar OS 5. The The post Polar OS 5 update adds dark maps, RPE grading and new widgets appeared first on Gadgets & Wearables.

Global Money Exchange Launches ‘Global Pay’ Mobile App powered by Comviva MUSCAT, Oman, Jan. 19, 2026 /PRNewswire/ — Global Money Exchange Co. LLC (GMEC), Oman’s leading money exchange company, today announced the launch of Global Pay, its new mobile application powered by Comviva’s mobiquity® Pay platform. This launch aligns with Oman’s national digital transformation vision …

Immunology biotech Agomab Therapeutics and eye-focused SpyGlass Pharma have both unveiled their intentions to go public, in the latest sign that the IPO window is reopening in 2026.

While availability of Sony Xperia handsets has dwindled over the last couple of years, those with the Xperia 1 and Xperia 5 IV might be happy to hear that LineageOS support is now available for the hardware. more…

AstraZeneca to acquire China rights for AbelZeta’s CAR-T therapy  Pharmaceutical Technology

(Telecompaper) OpenAI announced plans to start testing advertising in ChatGPT. This will start in the US in the coming weeks, in the free version and entry-level Go subscription of ChatGPT...

Anthropic and Google are the latest major players to announce AI tools designed for healthcare, following the launch of ChatGPT Health.

Hematology 2025 review of pivotal trial readouts, global regulatory approvals, safety and delivery considerations, and more key updates.

2025 review of how artificial intelligence reshaped healthcare delivery, diagnostics, drug development, regulation, and decision-making.

LOS ANGELES–(BUSINESS WIRE)–Following the recent announcement from WH Smith plc, Causeway Capital Management fully supports the Board’s recommendation to appoint Leo Quinn as Executive Chair of the company. Causeway, on behalf of its clients, is the largest shareholder in WH Smith. This decision comes at a critical juncture for the company, and we believe its …